Cargando…

Immune senescence in aged APP/PS1 mice

OBJECTIVES: To evaluate the linkage between age and deficits in innate and adaptive immunity which heralds both Alzheimer’s disease (AD) onset and progression. The pathobiological events which underlie and tie these outcomes remain not fully understood. METHODS: To investigate age-dependent immunity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelmoaty, Mai M., Yeapuri, Pravin, Machhi, Jatin, Lu, Yaman, Namminga, Krista L., Kadry, Rana, Lu, Eugene, Bhattarai, Shaurav, Mosley, Rodney Lee, Gendelman, Howard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659760/ https://www.ncbi.nlm.nih.gov/pubmed/38023614 http://dx.doi.org/10.1515/nipt-2023-0015

Ejemplares similares

Clinical biomarkers for Lewy body diseases
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
por: Abdelmoaty, Mai M., et al.
Publicado: (2022)

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
por: Markovic, Milica, et al.
Publicado: (2022)

Prodrug Therapies for Infectious and Neurodegenerative Diseases
por: Markovic, Milica, et al.
Publicado: (2022)

CD4+ effector T cells accelerate Alzheimer’s disease in mice
por: Machhi, Jatin, et al.
Publicado: (2021)

An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
por: Olson, Katherine E., et al.
Publicado: (2023)

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease
por: Mosley, R. Lee, et al.
Publicado: (2019)

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
por: Abdelmoaty, Mai M., et al.
Publicado: (2021)

Immunotherapy for Parkinson’s disease
por: Schwab, Aaron D., et al.
Publicado: (2020)

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
por: Olson, Katherine E., et al.
Publicado: (2021)

Multipolymer microsphere delivery of SARS-CoV-2 antigens
por: Shahjin, Farah, et al.
Publicado: (2023)

URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
por: Kiyota, Tomomi, et al.
Publicado: (2018)

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
por: Machhi, Jatin, et al.
Publicado: (2020)

Nanocarrier vaccines for SARS-CoV-2
por: Machhi, Jatin, et al.
Publicado: (2021)

A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
por: Machhi, Jatin, et al.
Publicado: (2021)

CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination
por: Herskovitz, Jonathan, et al.
Publicado: (2021)

Humanized Mice for Infectious and Neurodegenerative disorders
por: Dash, Prasanta K., et al.
Publicado: (2021)

The Immunopathobiology of SARS-CoV-2 Infection
por: Patel, Milankumar, et al.
Publicado: (2021)

Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson’s disease
por: Schutt, Charles R., et al.
Publicado: (2018)

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues
por: Kevadiya, Bhavesh D., et al.
Publicado: (2020)

Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs
por: Herskovitz, Jonathan, et al.
Publicado: (2021)

New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agents
por: Sharma, Mayank Kumar, et al.
Publicado: (2018)

Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease
por: Embury, Christine M, et al.
Publicado: (2016)

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
por: Saleh, Maamoon, et al.
Publicado: (2022)

Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
por: Teich, Andrew F., et al.
Publicado: (2018)

Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018)

Navβ2 knockdown improves cognition in APP/PS1 mice by partially inhibiting seizures and APP amyloid processing
por: Hu, Tao, et al.
Publicado: (2017)

Increased expression of Myc-interacting zinc finger protein 1 in APP/PS1 mice
por: Liu, Lu, et al.
Publicado: (2017)

The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
por: Machhi, Jatin, et al.
Publicado: (2020)

AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease
por: Kiyota, Tomomi, et al.
Publicado: (2015)

The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation
por: Dong, Weiguo, et al.
Publicado: (2016)

Multidimensional protein fractionation using ProteomeLab PF 2D™ for profiling amyotrophic lateral sclerosis immunity: A preliminary report
por: Schlautman, Joshua D, et al.
Publicado: (2008)

A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy
por: Araínga, Mariluz, et al.
Publicado: (2017)

Excitability and Synaptic Alterations in the Cerebellum of APP/PS1 Mice
por: Hoxha, Eriola, et al.
Publicado: (2012)

Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)

Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice
por: Chen, Lizhi, et al.
Publicado: (2019)

Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice
por: Lu, Xiaomei, et al.
Publicado: (2019)

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling
por: Li, Lei, et al.
Publicado: (2020)

Osteoblastic Swedish mutant APP expedites brain deficits by inducing endoplasmic reticulum stress-driven senescence
por: Pan, Jin-Xiu, et al.
Publicado: (2021)

Impairment of Dendrodendritic Inhibition in the Olfactory Bulb of APP/PS1 Mice
por: Li, Weiyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ndau8h0tchjsr7dkt1edh2pid6